CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 357 enrolled / 357 target
Drug / intervention
Merit WRAPSODY Endovascular Stent Graft +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04540302
NCT04540302N/ACompletedMonitor (5.6/mo)Completion was 28mo ago

Prospective, Randomized, Controlled, Multicenter Study Comparing the Merit WRAPSODY™ Endovascular Stent Graft to Percutaneous Transluminal Angioplasty for Treatment of Venous Outflow Circuit Stenosis or Occlusion in Hemodialysis Patients. The WAVE Study

Merit Medical Systems, Inc.·interventional·Posted Sep 7, 2020·Updated Jun 10, 2026

In Brief

A clinical study evaluating Merit WRAPSODY Endovascular Stent Graft and PTA for Venous Stenosis and Venous Occlusion. Completed, enrolled 357 participants across 43 sites in 4 countries.

Signals

Enrolling slower than its timeline implies

Detailed Summary

The purpose of the study is to demonstrate the safety and efficacy of the Merit WRAPSODY Endovascular Stent Graft for treatment of stenosis or occlusion within the dialysis access outflow circuit

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBrazil, Canada, United Kingdom, United States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 7, 2020
Enrollment StartMar 9, 2021
Primary CompletionFeb 22, 2024
Study CompletionJul 25, 2025
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 5.8 years ago

Arms & Interventions

AVF Peripheral study treatment groupexperimental

Subjects randomised to treatment with the WRAPSODY Endovascular Stent Graft

Device: Merit WRAPSODY Endovascular Stent Graft
AVF Peripheral control groupother

Subjects randomised to treatment with standard percutaneous transluminal angioplasty (PTA)

Device: PTA
AVG Anastomosisexperimental

All subjects in this single arm cohort will receive treatment with the WRAPSODY Endovascular Stent Graft

Device: Merit WRAPSODY Endovascular Stent Graft

Interventions

Merit WRAPSODY Endovascular Stent Graftdevice

Target lesion treated with stent graft placement

PTAdevice

Target lesion treated with standard percutaneous transluminal angioplasty (PTA)